Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters. ADMET DMPK. 2016;4(3):269-279. doi:10.5599/admet.4.3.328